PillRx only · Injection, Solution · Subcutaneous
Alirocumab
Brands: Praluent · Alirocumab
2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
2 active makers
2 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)—
US makers2 labelers
Packages10
DEA / ScheduleNone
US acquisition costNADAC · per unit
Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$257.911
Latest avg · Jun 17, 2026
+3%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*
Who makes it2 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | unknown | 6 | SUPPLYING |
| Sanofi-Aventis U.S. LLC | unknown | 4 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.